Literature DB >> 941543

[Ergotamine abuse and retroperitoneal fibrosis (author's transl)].

F Hofstädter.   

Abstract

A case of Ergotamine abuse causing considerable fibrotic changes of the abdominal aorta and iliac vessels and of the retroperitoneal space is reported. Histological and pathogenetic aspects of the arterial changes and the retroperitoneal fibrosis are discussed. They are referred to the permanent constriction of the Vasa vasorum by Ergotamine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 941543

Source DB:  PubMed          Journal:  Zentralbl Allg Pathol        ISSN: 0044-4030


  2 in total

1.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

2.  Retroperitoneal fibrosis after long-term daily use of ergotamine.

Authors:  L Damstrup; T T Jensen
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.